These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 574529
1. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole. Takagi LR, Gulling EA, O'Leary JA. J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529 [No Abstract] [Full Text] [Related]
2. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories. Southern EM, Gutknecht GD. Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407 [Abstract] [Full Text] [Related]
4. Extra amniotic prostaglandins in the management of intrauterine fetal death, anencephaly and hydatidiform mole. Embrey MP, Calder AA, Hillier K. J Obstet Gynaecol Br Commonw; 1974 Jan; 81(1):47-51. PubMed ID: 4818316 [No Abstract] [Full Text] [Related]
5. The use of prostaglandin E 2 in the management of intrauterine death, missed abortion and hydatidiform mole. Filshie GM. J Obstet Gynaecol Br Commonw; 1971 Jan; 78(1):87-90. PubMed ID: 5557677 [No Abstract] [Full Text] [Related]
6. A prostaglandin analogue (ONO-802) in treatment of missed abortion, intrauterine fetal death and hydatiform mole: a dose-finding trial. Garcea N, Dargenio R, Panetta V, Moneta E, Tancredi G, Giannitelli A. Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):15-22. PubMed ID: 3595971 [Abstract] [Full Text] [Related]
9. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole. Karim SM. Br Med J; 1970 Jul 25; 3(5716):196-7. PubMed ID: 5448780 [Abstract] [Full Text] [Related]
11. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death. Thiery M, Amy JJ, Decoster JM. Z Geburtshilfe Perinatol; 1979 Jun 25; 183(3):218-22. PubMed ID: 483950 [Abstract] [Full Text] [Related]
12. Prostaglandins for inducing labor and abortion. Drug Ther Bull; 1973 May 25; 11(11):41-3. PubMed ID: 4728968 [No Abstract] [Full Text] [Related]
13. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion. Bailey CD, Newman C, Ellinas SP, Anderson GG. Obstet Gynecol; 1975 Jan 25; 45(1):110-3. PubMed ID: 1110809 [Abstract] [Full Text] [Related]
14. Protocol for management of unsuccessful pregnancy. Hodgson JE, Ditmanson GM. Minn Med; 1980 Feb 25; 63(2):134-8. PubMed ID: 7382975 [Abstract] [Full Text] [Related]
16. Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy. Calder AA, Mackenzie IZ, Embrey MP. J Reprod Med; 1976 May 25; 16(5):271-5. PubMed ID: 933106 [Abstract] [Full Text] [Related]
17. [Clinico-experimental results of the use of alpha F2 prostaglandin in some obstetrical physiopathological conditions]. Proto M, Casati G. Minerva Ginecol; 1975 Jul 25; 27(7):523-36. PubMed ID: 1207954 [No Abstract] [Full Text] [Related]
18. Termination of abnormal intrauterine pregnancies with intramuscular administration of dihomo 15 methyl prostaglandin F 2alpha. Karim SM, Ratnam SS. Br J Obstet Gynaecol; 1976 Nov 25; 83(11):885-9. PubMed ID: 990229 [Abstract] [Full Text] [Related]
20. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole. Arshat H. Med J Malaysia; 1977 Mar 25; 31(3):220-5. PubMed ID: 904515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]